The test will complement the already existing Cue molecular COVID-19 test and will be compatible with the Cue Health Monitoring System and the Cue Health Mobile Application, according to a Jan. 6 press release.
“An omicron-specific test will assist clinicians in providing patients better treatment options and containment strategies at the time of a positive diagnosis,” Cue CEO Ayub Khattak said in the press release.
Since 2018, HHS’ BARDA has funded Cue Health projects like over-the-counter influenza diagnostic cartridges for its monitoring system and its portable COVID-19 test.
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
